A 67-year-old postmenopausal woman has a DEXA scan showing a T-score of -2.7 at the femoral neck. She has no history of fragility fractures but has a FRAX 10-year probability of major osteoporotic fracture of 25%. What is the most appropriate pharmacologic management?